Research/art/teacher profile of a person
Name and surname:
PharmDr. Nikola Chomaničová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Chomaničová
I.2 - Name
Nikola
I.3 - Degrees
PharmDr., PhD.
I.4 - Year of birth
1993
I.5 - Name of the workplace
Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine/ Department of Pharmacology and Toxicology, Faculty of Pharmacy
I.6 - Address of the workplace
Sasinkova 4, 811 08 Bratislava/ Odbojárov 10, 832 32 Bratislava
I.7 - Position
Assistant Professor
I.8 - E-mail address
nikola.chomanicova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/58645
I.10 - Name of the study field in which a person works at the university
General Medicine, Pharmacy
I.11 - ORCID iD
0000-0003-1411-4378

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava
II.b - Year
2017
II.c - Study field and programme
Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University in Bratislava
II.b - Year
2021
II.c - Study field and programme
Pharmacy, Pharmacology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assistant professor Faculty of Pharmacy, Comenius University in Bratislava 09/2023- present
researcher Clinical Research Unit, V. Internal Clinic, Faculty of Medicine, Comenius University in Bratislava 11/2025-08/2026
researcher Slovak Center of Scientific and Technical Information 10/2021- 06/2025
pharmacist Pharmacy Rubicon 08/2021-10/2021
assistant professor Faculty of Medicine, Comenius University in Bratislava 09/2026- present

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
First aid instructor course Emergency Medical Service Operations Centre of the Slovak Republic 2026
Emergency life support course RZP Trenčín 2026

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pharmacology General Medicine I.+II. General Medicine
General Biology Pharmacy I.+II. Pharmacy
Anatomy and Physiology Pharmacy I.+II. Pharmacy
Pathology Pharmacy I.+II. Pharmacy
Human Biology Medical and diagnostic devices I. Medical and diagnostic devices
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
1
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
60
VI.1.b - Over the last six years
44
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
17
VI.1.b - Over the last six years
14
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
220
VI.1.b - Over the last six years
220
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
220
VI.1.b - Over the last six years
220
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Chomanicova N, Gazova A, Adamickova A, Valaskova S, Kyselovic J. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin. Physiol Res. 2021 Aug 31; 70(4):501-508. doi: 10.33549/physiolres.934618.

2

Chomaničová N, Adamičková A, Cervenak Z, Valášková S, Gažová A, Kyselovic J. Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs. Int J Mol Sci. 2026 May 6;27(9):4146. doi: 10.3390/ijms27094146.

3

Chomanicova N, Adamickova A, Valaskova S, Gazova A, Kyselovic J. Caco-2 Monolayer as a Model of the Intestinal Barrier: Permeability of Magnesium Salts. Methods Mol Biol. 2024;2835:301-306. doi: 10.1007/978-1-0716-3995-5_25.

4

Nakládal D, Oerlemans R, Molitorisová M, Chomaničová N, Zorkócy G, Yoseif C, van der Graaf AC, Stuchlík S, Krenning G, Groves MR, Heeres A, Levarski Z, Kyselovič J, Henning RH, Deelman LE. New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase. SLAS Discov. 2025 Apr;32:100234. doi: 10.1016/j.slasd.2025.100234.

5

Čendula R, Chomaničová N, Adamičková A, Gažová A, Kyselovič J, Máťuš M. Altered Expression of ORAI and STIM Isoforms in Activated Human Cardiac Fibroblasts. Physiol Res. 2021 Nov 30;70(Suppl 1):S21-S30. PMID: 35503047.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Chomanicova N, Gazova A, Adamickova A, Valaskova S, Kyselovic J. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin. Physiol Res. 2021 Aug 31; 70(4):501-508. doi: 10.33549/physiolres.934618.

2

Chomaničová N, Adamičková A, Cervenak Z, Valášková S, Gažová A, Kyselovic J. Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs. Int J Mol Sci. 2026 May 6;27(9):4146. doi: 10.3390/ijms27094146.

3

Chomanicova N, Adamickova A, Valaskova S, Gazova A, Kyselovic J. Caco-2 Monolayer as a Model of the Intestinal Barrier: Permeability of Magnesium Salts. Methods Mol Biol. 2024;2835:301-306. doi: 10.1007/978-1-0716-3995-5_25.

4

Nakládal D, Oerlemans R, Molitorisová M, Chomaničová N, Zorkócy G, Yoseif C, van der Graaf AC, Stuchlík S, Krenning G, Groves MR, Heeres A, Levarski Z, Kyselovič J, Henning RH, Deelman LE. New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase. SLAS Discov. 2025 Apr;32:100234. doi: 10.1016/j.slasd.2025.100234.

5

Čendula R, Chomaničová N, Adamičková A, Gažová A, Kyselovič J, Máťuš M. Altered Expression of ORAI and STIM Isoforms in Activated Human Cardiac Fibroblasts. Physiol Res. 2021 Nov 30;70(Suppl 1):S21-S30. PMID: 35503047.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

2026 [01/20] / Netherlands – Anselmi, C.; Dal-Fabbro, R.; Abada, H.; Mendes Soares, I.P.; Cardoso, L.M.; Mahmoud, A.H.; Catalano, J.C.; Gomes de Carvalho, A.B.; Han, Y.; Sikder, P.; Schwendeman, A.; Hebling, J.; Bottino, M.C. Bilayer gelatin-methacryloyl scaffold for pulp inflammation suppression and dentin-like tissue regeneration. Journal of Controlled Release. 2026;389:114469. DOI: 10.1016/j.jconrel.2025.114469.

2

2025 [01/20] / United States – Lei, W.; Wang, X.; Cai, J.; Pan, L. Mesenchymal and Pluripotent Stem Cell-Based Strategies for Cardiac Regeneration: Mechanisms, Challenges, and Future Directions. Biotechnology Journal. 2025;20(11):e70152. DOI: 10.1002/biot.70152.

3

2025 [01/20] / United Kingdom – Loo, A.L.S.J.; Cen, R.; Wang, J.; Wu, Z.; Duncan, H.F.; Lee, A.H.C.; Zhang, C. Symptom correlation and spatial distribution of inflammatory mediators in pulpitis: A preliminary study. International Endodontic Journal. 2025;58(10):1565–1581. DOI: 10.1111/iej.14275.

4

2024 [01/20] / United Kingdom – Yan, W.; Xia, Y.; Zhao, H.; Xu, X.; Ma, X.; Tao, L. Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions. Journal of Molecular and Cellular Cardiology. 2024;188:1–14. DOI: 10.1016/j.yjmcc.2023.12.009.

5

2025 [01/20] / United States – Askarizadeh, F.; Almahmeed, W.; Abass, K.S.; Virani, S.; Sahebkar, A. Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: A Comprehensive Review of Mechanisms and Therapeutic Implications. Current Atherosclerosis Reports. 2025;27(1):114. DOI: 10.1007/s11883-025-01358-z.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV-23-0178: Advancing innovative treatments targeting sulfur biochemistry. (co-investigator)

2

VEGA-1/0523/25: New therapeutic strategies in the cardiac regeneration based on in natural and induced signal pathways of myosin switch and intercalated disc protein. (co-investigator)

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2026-09-01